Top Markets
Coin of the day
Tricida, Inc. Tricida, Inc.

Tricida, Inc.

TCDA
Rank in Stocks #35026
Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the... Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the advancement and market introduction of veverimer (TRC101). This compound, an orally ingested, non-systemic polymer, has successfully concluded its Phase III clinical trials. Veverimer is designed to address metabolic acidosis in individuals suffering from chronic kidney disease by specifically targeting and eliminating excess acid within the gastrointestinal tract. The company was established in 2013 and is headquartered in South San Francisco, California.
Share Price
$0.108
Last synced: 2023-01-23
Market Cap
$4.56M
Change (1 day)
-10.00%
Change (1 year)
0.00%
Country
US
Trade Tricida, Inc. (TCDA)

Category

Stock price history for Tricida, Inc. (TCDA)
Highest end of day price: $0.16 on 2023-01-01

Lowest end of day price: $27.95 on 2018-06-01
Stock price history of Tricida, Inc. from 2018 to 2026
Annual Stock Price Performance
Year Performance
2023 -15.79%
2022 -97.77%
2021 12.62%
2020 -81.33%
2019 39.94%
2018 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE